These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10088972)

  • 1. Hyperdiploidy and apparent aneusomy in mesothelial cells from non-malignant effusions as detected by fluorescence in situ hybridization (FISH).
    Fiegl M; Zojer N; Kaufmann H; Müllauer L; Schuster R; Huber H; Drach J
    Cytometry; 1999 Feb; 38(1):15-23. PubMed ID: 10088972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma.
    Fiegl M; Kaufmann H; Zojer N; Schuster R; Wiener H; Müllauer L; Roka S; Huber H; Drach J
    Hum Pathol; 2000 Apr; 31(4):448-55. PubMed ID: 10821492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients.
    Zojer N; Fiegl M; Angerler J; Müllauer L; Gsur A; Roka S; Pecherstorfer M; Huber H; Drach J
    Br J Cancer; 1997; 75(3):403-7. PubMed ID: 9020486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH).
    Fiegl M; Massoner A; Haun M; Sturm W; Kaufmann H; Hack R; Krugmann J; Fritzer-Szekeres M; Grünewald K; Gastl G
    Br J Cancer; 2004 Aug; 91(3):558-63. PubMed ID: 15226776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hyperdiploid malignant cells in body cavity effusions by fluoresence in situ hybridization on ThinPrep slides.
    Florentine BD; Sanchez B; Raza A; Frankel K; Martin SE; Kovacs B; Felix JC
    Cancer; 1997 Oct; 81(5):299-308. PubMed ID: 9349518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.
    Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J
    J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer.
    Roka S; Fiegl M; Zojer N; Filipits M; Schuster R; Steiner B; Jakesz R; Huber H; Drach J
    Breast Cancer Res Treat; 1998 Mar; 48(2):125-33. PubMed ID: 9596484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.
    Drach J; Schuster J; Nowotny H; Angerler J; Rosenthal F; Fiegl M; Rothermundt C; Gsur A; Jäger U; Heinz R
    Cancer Res; 1995 Sep; 55(17):3854-9. PubMed ID: 7641204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FISH cytogenetics and prognosis in breast and non-small cell lung cancers.
    Massoner A; Augustin F; Duba HC; Zojer N; Fiegl M
    Cytometry B Clin Cytom; 2004 Nov; 62(1):52-6. PubMed ID: 15468329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects.
    Zojer N; Fiegl M; Müllauer L; Chott A; Roka S; Ackermann J; Raderer M; Kaufmann H; Reiner A; Huber H; Drach J
    Br J Cancer; 1998 Apr; 77(8):1337-42. PubMed ID: 9579843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hyperdiploid malignant cells in pleural effusions with chromosome-specific probes and fluorescence in situ hybridization.
    Johnson TM; Kuffel DG; Dewald GW
    Mayo Clin Proc; 1996 Jul; 71(7):643-8. PubMed ID: 8656705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients.
    Schenk T; Ackermann J; Brunner C; Schenk P; Zojer N; Roka S; Drach J
    Chest; 1997 Jun; 111(6):1691-6. PubMed ID: 9187195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach for quantitative assessment of fluorescence in situ hybridization (FISH) signals for applied human molecular cytogenetics.
    Iourov IY; Soloviev IV; Vorsanova SG; Monakhov VV; Yurov YB
    J Histochem Cytochem; 2005 Mar; 53(3):401-8. PubMed ID: 15750029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer.
    Schlüter B; Gerhards R; Strumberg D; Voigtmann R
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1389-400. PubMed ID: 20217132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response studies of the induction of hyperdiploidy and polyploidy by diethylstilbestrol and 17beta-estradiol in cultured human lymphocytes using multicolor fluorescence in situ hybridization.
    Schuler M; Hasegawa L; Parks R; Metzler M; Eastmond DA
    Environ Mol Mutagen; 1998; 31(3):263-73. PubMed ID: 9585265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the UroVysion
    Rosolen DCB; Faria DK; Faria CS; Antonangelo L
    Cancer Med; 2018 May; 7(5):1967-1977. PubMed ID: 29577646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells.
    Eastmond DA; Schuler M; Rupa DS
    Mutat Res; 1995 Dec; 348(4):153-62. PubMed ID: 8544867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.
    Fiegl M; Tueni C; Schenk T; Jakesz R; Gnant M; Reiner A; Rudas M; Pirc-Danoewinata H; Marosi C; Huber H
    Br J Cancer; 1995 Jul; 72(1):51-5. PubMed ID: 7599066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.